Multiple compounds that ameliorate NAFL and/or NASH, including salidroside, salvianolic acid A, quercetin plus allopurinol, and retinoic acid, function through inhibition of hepatic Txnip expression 26-29, suggesting a pathogenic role of TXNIP in NASH development. This evidence concerns the gene TXNIP and metabolic dysfunction-associated steatohepatitis.